Quick Answer
Matinas BioPharma Holdings, Inc. reported Shares Outstanding of 6.41 million shares for fiscal year 2025.
Matinas BioPharma Holdings, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 6.41M | +25.9% |
| 2024 | 5.09M | +17.1% |
| 2023 | 4.35M | -98.0% |
| 2022 | 217.26M | +0.5% |
| 2021 | 216.27M | +8.1% |
| 2020 | 200.11M | +22.7% |
| 2019 | 163.16M | +17147.0% |
| 2019 | 946,000 | -99.2% |
| 2018 | 113.29M | +21.3% |
| 2017 | 93.37M | +60.5% |
| 2016 | 58.16M | +1.7% |
| 2015 | 57.18M | +77.1% |
| 2014 | 32.29M | +0.9% |
| 2013 | 32.00M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 5.90M | +16.0% | +16.0% |
| June 30, 2025 | 5.09M | -98.0% | +0.0% |
| March 31, 2025 | 5.09M | -97.7% | +0.0% |
| December 31, 2024 | 5.09M | +17.1% | +0.0% |
| September 30, 2024 | 5.09M | -97.7% | -98.0% |
| June 30, 2024 | 250.82M | +15.4% | +15.3% |
| March 31, 2024 | 217.48M | +0.1% | +4905.0% |
| December 31, 2023 | 4.35M | -98.0% | -98.0% |
- Matinas BioPharma Holdings, Inc. showed an increase of +25.9% in Shares Outstanding compared to the prior fiscal year.
- Over the 2013–2025 period, Matinas BioPharma Holdings, Inc.’s shares outstanding has declined by 80.0% (from 32.00 million shares to 6.41 million shares).
- The most recent figure is from Matinas BioPharma Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: